Literature DB >> 11438726

Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.

M Riewald1, W Ruf.   

Abstract

The crucial role of cell signaling in hemostasis is clearly established by the action of the downstream coagulation protease thrombin that cleaves platelet-expressed G-protein-coupled protease activated receptors (PARs). Certain PARs are cleaved by the upstream coagulation proteases factor Xa (Xa) and the tissue factor (TF)--factor VIIa (VIIa) complex, but these enzymes are required at high nonphysiological concentrations and show limited recognition specificity for the scissile bond of target PARs. However, defining a physiological mechanism of PAR activation by upstream proteases is highly relevant because of the potent anti-inflammatory in vivo effects of inhibitors of the TF initiation complex. Activation of substrate factor X (X) by the TF--VIIa complex is here shown to produce enhanced cell signaling in comparison to the TF--VIIa complex alone, free Xa, or Xa that is generated in situ by the intrinsic activation complex. Macromolecular assembly of X into a ternary complex of TF--VIIa--X is required for proteolytic conversion to Xa, and product Xa remains transiently associated in a TF--VIIa--Xa complex. By trapping this complex with a unique inhibitor that preserves Xa activity, we directly show that Xa in this ternary complex efficiently activates PAR-1 and -2. These experiments support the concept that proinflammatory upstream coagulation protease signaling is mechanistically coupled and thus an integrated part of the TF--VIIa-initiated coagulation pathway, rather than a late event during excessive activation of coagulation and systemic generation of proteolytic activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438726      PMCID: PMC35412          DOI: 10.1073/pnas.141126698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

Authors:  C T Esmon
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

2.  Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa.

Authors:  W Ruf; C D Dickinson
Journal:  Trends Cardiovasc Med       Date:  1998-11       Impact factor: 6.677

3.  Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.

Authors:  E G Fischer; M Riewald; H Y Huang; Y Miyagi; Y Kubota; B M Mueller; W Ruf
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

4.  The effect of leukocyte elastase on tissue factor pathway inhibitor.

Authors:  D A Higuchi; T C Wun; K M Likert; G J Broze
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

5.  Effect of soluble tissue factor on the kinetic mechanism of factor VIIa: enhancement of p-guanidinobenzoate substrate hydrolysis.

Authors:  M A Payne; P F Neuenschwander; A E Johnson; J H Morrissey
Journal:  Biochemistry       Date:  1996-06-04       Impact factor: 3.162

6.  Exosite interactions determine the affinity of factor X for the extrinsic Xase complex.

Authors:  R J Baugh; C D Dickinson; W Ruf; S Krishnaswamy
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

7.  Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active.

Authors:  E Camerer; J A Rottingen; J G Iversen; H Prydz
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

8.  Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.

Authors:  B M Mueller; W Ruf
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

9.  An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma.

Authors:  W Ruf; T S Edgington
Journal:  Thromb Haemost       Date:  1991-11-01       Impact factor: 5.249

10.  Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.

Authors:  J R Sevinsky; L V Rao; W Ruf
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  87 in total

Review 1.  Protease activated receptor 2 and the cardiovascular system.

Authors:  Carla Cicala
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells.

Authors:  Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-03-15       Impact factor: 3.162

3.  Can we stabilize unstable plaque?

Authors:  Rodolfo Paoletti; Andrea Cignarella
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 4.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

5.  Endothelial protein C receptor is required for tissue factor ternary complex signaling in the mouse.

Authors:  J Disse; W Ruf
Journal:  J Thromb Haemost       Date:  2011-12       Impact factor: 5.824

6.  Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.

Authors:  Silvio Antoniak; Mauricio Rojas; Denise Spring; Tara A Bullard; Edward D Verrier; Burns C Blaxall; Nigel Mackman; Rafal Pawlinski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-19       Impact factor: 8.311

7.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Authors:  Yuichi Kamikubo; G Loredana Mendolicchio; Antonella Zampolli; Patrizia Marchese; Andrea S Rothmeier; Jennifer Nagrampa Orje; Andrew J Gale; Sriram Krishnaswamy; András Gruber; Henrik Østergaard; Lars C Petersen; Wolfram Ruf; Zaverio M Ruggeri
Journal:  Blood       Date:  2017-07-20       Impact factor: 22.113

Review 8.  Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism.

Authors:  Pei Wang; Yunfei Wu; Xiaoming Li; Xiaofeng Ma; Liangwei Zhong
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

10.  Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.

Authors:  Frank Niessen; Christian Furlan-Freguia; José A Fernández; Laurent O Mosnier; Francis J Castellino; Hartmut Weiler; Hugh Rosen; John H Griffin; Wolfram Ruf
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.